Novaremed
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Total raised
€129M
€129,223,066
Funding rounds
2
Investors
1
distinct backers
Active since
2020-09
latest 2022-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood20
base rate 12% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-25 | Other | €127M | NeuroFront Therapeutics | View deal → |
| 2020-09-21 | Other | €2.3M | — | View deal → |
Investors
1Related news
- Novaremed receives USD 130 million in exclusive license agreementstartupticker.ch · 2022-07
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy